Think of it as an internal antioxidant shield, helping to neutralise free radicals caused by UV exposure, pollution, and daily stressors
What Adults Need to Know 5
Each pen is designed for single use and contains a precise dose of tirzepatide in a ready-to-inject solution
Tirzepatides unique mechanism of action, which activates both GLP-1 and GIP receptors, may contribute to its effectiveness
Once approved, here is what the pricing landscape looks like based on comparable drugs: Semaglutide (Wegovy) without insurance runs $1,300 to $1,600 per month in the US Tirzepatide (Zepbound) without insurance runs $1,000 to $1,300 per month in the US Retatrutide, as a next-generation triple agonist, will likely land at $1,200 to $1,800 per month at launch In Australia, the UK, and Canada, prices tend to be lower due to government drug pricing controls